An Interview With Paul Bolno, MD, CEO of Wave Life Sciences

Episode 109,   Jan 04, 2024, 07:50 PM

Headliner
Share
Subscribe

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Paul Bolno, MD, the CEO of Wave Life Sciences, whose investigational therapy WVE-003 is a potential treatment for Huntington disease.

Share
Subscribe
Next
An Interview With Kyle Bryant, Director of the Ambassador Program at the Friedreich's Ataxia Research Alliance
Top episodes
An Interview WIth Tracy Sharp, a Patient With Lambert-Eaton Myasthenic Syndrome
by Rare Care Podcast
An Interview with Josh Disbrow, CEO of Aytu Bio
by Rare Care Podcast
An Interview With Omer Abdul Hamid, MD, of Nemours Children's Hospital in Orlando, Florida
by Rare Care Podcast